Skip to main content

Hyperion Defi, Inc.

HYPD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001682639

No open-market purchases or sales by Hyperion Defi, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $7.92M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Hyperion Defi, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of HYPD: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders2831+3
Shares4.08M3.85M−226.9K (−5.6%)
Value$12.5M$7.51M−$4.94M (−39.7%)

New holders (7)

Institutions that held Hyperion Defi, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to HYPD in Q2 2022
InstitutionSharesValue% of portfolio
Bridgeway Capital Management, LLC47,900$93.0K0.00%
Two Sigma Securities, LLC30,363$59.0K0.01%
Prudential Financial Inc17,000$33.0K0.00%
Jane Street Group, LLC12,519$24.0K0.00%
Essex Investment Management Co LLC3,300$6.00K0.00%
Captrust Financial Advisors3,000$6.00K0.00%
HC Financial Advisors Inc2,500$5.00K0.00%

Sold out (4)

Institutions that held Hyperion Defi, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of HYPD in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Marshall Wace, LLP27,688$84.0K
Susquehanna International Group, LLP17,902$55.0K
AMH Equity Ltd12,152$37.0K
Cutler Group LP100$0